Curious how foam sclerotherapy works? Watch an animation here. For more vein procedure videos, go to La Jolla Vein Care’s Youtube channel.
In November of 2013, the US Food and Drug Administration (FDA) approved Varithena,™ a new type of foam treatment for the treatment of patients with incompetent veins and visible varicosities of the great saphenous vein (GSV) system. Varithena™ is a pharmaceutical-grade, low-nitrogen, polidocanol foam dispensed from a canister device. In two pivotal, placebo-controlled Phase III trials, VANISH-1 and VANISH-2, Varithena™ achieved a clinically meaningful improvement in the symptoms of superficial venous incompetence and the appearance of visible varicosities and addressed the underlying venous incompetence in the majority of patients treated. Varithena™ (polidocanol injectable foam) is a sclerosing agent indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins and visible varicosities of the great saphenous vein system above and below the knee. Varithena™ improves the symptoms of superficial venous incompetence and the appearance of visible varicosities. Treatment is a minimally invasive, non-surgical procedure that requires neither tumescent anesthesia nor sedation. Foam sclerotherapy has been used for years by medical doctors. What is new with Varithena™ , is that the foam is pre-made with low-nitrogen as opposed to room air, and is dispensed in a proprietary canister. It is not yet available in doctors offices. Making Foam
La Jolla Vein Care
9850 Genesee Avenue Suite 410 La Jolla, California 92037-1212 Tel: (858) 550-0330 Fax: (858) 550-0676 firstname.lastname@example.org